ICON plc has entered an agreement to acquire Aptiv Solutions for $143.5 million in cash. The acquisition is subject to certain closing conditions.   Aptiv, headquartered in Reston, VA, has operations in 16 countries for the design and execution of adaptive clinical trials for pharma and biopharma companies. The company’s ADDPLAN software supports the design, simulation and analysis of adaptive trials and is used by regulatory agencies, pharma and medical device companies, and academia.   Additio...